Sign in: Staff/Students
A map tracking the spread of a bacterial strain of clostridium difficile
Scientists at the University of Liverpool have identified the origin of an epidemic strain of Clostridium difficile (027) and its mode of spread using tagging genetic signatures in the DNA of bacteria, some of them associated with its increased virulence.
Clostridium difficile is the most common cause of antibiotic-associated diarrhoea and healthcare-related infection in the developed world. On average, ill patients display symptoms for more than 10 days and a third develop severe disease, including bloody diarrhoea and septicaemia. Until now, however, the key moments in the infection’s evolutionary history have remained unknown.
Outbreaks in North America
Scientists at Liverpool, in collaboration with the Wellcome Trust Sanger Institute, Hinxton, and a number of investigators worldwide, have discovered that a more virulent strain of the bacteria originated from two outbreaks in North America in 2003-4, thought to have been driven by widespread prescription of broad spectrum antibiotics.
This particular strain quickly spread throughout Europe, including a notorious outbreak at Stoke Mandeville Hospital. Using next generation microbial sequencing, evolutionary analysis and epidemiological information, the team identified subtle signatures in the bacteria’s genome that allowed them to pinpoint its worldwide spread.
The data suggests that there were at least four routes of entry for this epidemic strain into UK, three of which arrived independently from North America in Exeter, Ayrshire and Birmingham, and another one which arrived in Maidstone from continental Europe.
Dr Fabio Miyajima, from the University’s Institute of Translational Medicine, said: “We know these organisms are resistant to commonly prescribed antibiotics and disinfectants, including alcohol gel, but perhaps more intriguing is the fact that its rapid spread throughout the world has been more about the ease and frequency with which we travel today.”
Clostridium difficile is air borne and can be transmitted from infected patients to others. Since it survives in the environment for weeks, there is also a strong possibility that healthy individuals who shared a contaminated ambient could transport the spores through clothing, or even on their hands and hair.
He added: “It is important for us to know the ways in which the bacteria can enter various countries so that we can predict just how widespread the infection may become. Importantly, the same techniques can now also be used to track an outbreak within a hospital and community to ensure that it is controlled as rapidly as possible.”
Professor Munir Pirmohamed, NHS Chair in Pharmacogenetics and Head of the Wolfson Centre for Personalised Medicine, added: “This is the result of work that was carried out as part of the Liverpool NIHR Biomedical Research Centre. It has now resulted in the award of a £2.4 million program grant from the Medical Research Council, in partnership with the London School of Hygiene and Tropical Medicine and the Wellcome Trust Sanger Institute, which will allow us to build on this work and understand the interactions between the microbial genome, its environment and the patient.
“Our goal is to answer key medical questions, such as why we can’t predict who will contract the condition and why, despite rigorous cleaning procedures to reduce Clostridium difficile, a significant number of people still get it.”
The research is published in Nature Genetics and funded by the Medical Research Council (MRC).
It would be interesting to study immune responses to exposure to Clostridium difficile bacteria to understand why some people get infected whereas others do not.
In my opinion it would be likely cost effective to strenghten the immune system naturally and reducing risks to all sorts of communicable diseases than spending huge financial resources looking for chemical ways to attacking the microbes who incidentally are our synergistic partners in our global ecology. Otherwise, here we are facing off with chemical-resistant strains: a microbial response to our chemical attack on the microbes.
Attack natural threats with natural responses!
Very important research. Interesting to know how the epidemic has started in the UK and its origin.
Still cannot explain the relative absence of this infection in places like India, where antibiotic usage is still not under a strict policy control and widespread antibiotic prescription is rampant, although travel to and from India is not different from UK/Europe/US.
You must be logged in to post a comment.
All recent news
Taxis and Licenced Vehicles: Travelling safely in the city
Exam & Assessment Timetable Release – Tuesday, 6 December
Off-patent liver disease drug could prevent COVID-19 infection
Jeanne Dielman: ‘greatest film of all time’ is a masterpiece of slow cinema that richly details life’s quiet intricacies
‘Find a Housemate’ meet-ups and LSH Housing Fair in December
An off-patent liver disease drug could prevent #COVID19 infection, a new @Nature study has found.
@livuniHLS scientists played a key role in the collaborative study, which involved a unique mix of ‘mini-organs’, donor organs, animal studies & patients.
“This research is our voice. This research is all the voices everyone says they want to hear but no one wants to listen to”.
Research from @livuni, @ucl & @unisouthampton investigates the effects of Covid-19 on children seeking asylum in the UK. ⤵️
Don't just take my word for it. Here are other sources of information about Group A Strep. https://www.sciencemediacentre.org/expert-reaction-to-uk-strep-a-outbreaks/ and for worried parents worth looking at @Damian_Roland on https://youtu.be/FABmKjCvvvQ https://twitter.com/LBC/status/1599371637870166018